Neuroblastoma metastatic to the central nervous system - The Memorial Sloan-Kettering Cancer Center experience and a literature review

被引:1
|
作者
Kramer, K
Kushner, B
Heller, G
Cheung, NKV
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
neuroblastoma; central nervous system metastases; lumbar punctures;
D O I
10.1002/1097-0142(20010415)91:8<1510::AID-CNCR1159>3.3.CO;2-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND, The central nervous system (CNS) can be a sanctuary site for cancer cells, because the blood-brain barrier impedes penetration of most chemotherapeutic agents. The authors hypothesized that, with improved survival from childhood metastatic neuroblastoma (NB), the incidence of CNS (intraparenchymal and leptomeningeal) spread may increase. They undertook this study to assess the frequency of CNS NB, to analyze risk factors and treatment options, and to review the literature. METHODS. The authors retrospectively analyzed all patients with metastatic NB who were treated on protocols N4, N5, N6, and N7 from 1980 to 1999 at Memorial. Sloan-Kettering Cancer Center (MSKCC), during which time there was an increase in the overall survival rate. RESULTS. Two hundred fifty-one patients with Stage 4 NB (Group 251) were studied, of which 127 (Group 127) were newly diagnosed patients who were treated initially at MSKCC. None had CNS NB at the time of diagnosis. Eleven patients developed documented CNS disease; 8 of these 11 recurrences were isolated in the CNS. For Group 127, the overall incidence rate of CNS NB was 6.3%, with an increase in incidence from N4-N5 to N6-N7 of from 1.7% to 11.7%. Seven patients had isolated CNS disease recurrences. Only lumbar punctures (LP) performed near the time of diagnosis in patients with known bone marrow involvement were associated with subsequent development of CNS disease. For the entire group of 251 patients, lumbar puncture at the time of diagnosis and elevated serum lactic dehydrogenase levels were prognostic. Among the larger series reported in the literature, CNS involvement from metastatic lesions was rare at the time of diagnosis and remained an uncommon complication. CONCLUSIONS. The incidence of CNS NB may be increasing. Because it is the sole site of disease recurrence in 64% of patients, the CNS may represent a sanctuary site for NB. CNS NB is associated with diagnostic lumbar punctures in patients with known bone marrow disease, raising the possibility that circulating or epidural microscopic tumor cells may seed the craniospinal axis. Cancer 2001;91: 1510-9. (C) 2001 American Cancer Society.
引用
收藏
页码:1510 / 1519
页数:10
相关论文
共 50 条
  • [41] Salvage therapy for germ cell tumours at the Memorial Sloan-Kettering Cancer Center
    Berg, WJ
    Bosl, GJ
    Bajorin, DF
    Motzer, RJ
    GERM CELL TUMOURS IV, 1998, : 349 - 354
  • [42] Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience
    Khasraw, M.
    Holodny, A.
    Goldlust, S. A.
    DeAngelis, L. M.
    ANNALS OF ONCOLOGY, 2012, 23 (02) : 458 - U438
  • [43] Acute Care Nurse Practitioners in Oncologic Critical Care: The Memorial Sloan-Kettering Cancer Center Experience
    D'Agostino, Rhonda
    Halpern, Neil A.
    CRITICAL CARE CLINICS, 2010, 26 (01) : 207 - +
  • [44] MALIGNANT GERM-CELL TUMORS (MGCT) IN CHILDREN MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE
    WOLLNER, N
    LUKS, E
    WACHTEL, T
    GHAVIMI, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 306 - 306
  • [45] Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience.
    Ganetsky, A.
    Adel, N. G.
    Frattini, M. G.
    Maslak, P. G.
    Heaney, M. L.
    Jurcic, J. G.
    Tallman, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Liver involvement in neuroblastoma: The memorial Sloan-Kettering experience supports treatment reduction in young patients
    Kushner, BH
    Kramer, K
    LaQuaglia, MP
    Modak, S
    Cheung, NKV
    PEDIATRIC BLOOD & CANCER, 2006, 46 (03) : 278 - 284
  • [47] INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER: AN UPDATE OF THE MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE
    Setton, Jeremy
    Caria, Nicola
    Romanyshyn, Jonathan
    Koutcher, Lawrence
    Wolden, Suzanne L.
    Zelefsky, Michael J.
    Rowan, Nicholas
    Sherman, Eric J.
    Fury, Matthew G.
    Pfister, David G.
    Wong, Richard J.
    Shah, Jatin P.
    Kraus, Dennis H.
    Shi, Weiji
    Zhang, Zhigang
    Schupak, Karen D.
    Gelblum, Daphna Y.
    Rao, Shyam D.
    Lee, Nancy Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 291 - 298
  • [48] Patterns of care and outcomes in patients with intracranial hemangiopericytomas: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Dankwah-Quansah, M. A.
    Gutin, P.
    Bilsky, M.
    Huse, J.
    Rosenblum, M.
    Abrey, L. E.
    DeAngelis, L.
    Omuro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Irinotecan and Temozolomide for Ewing Sarcoma: The Memorial Sloan-Kettering Experience
    Casey, Denise A.
    Wexler, Leonard H.
    Merchant, Melinda S.
    Chou, Alexander J.
    Merola, Pamela R.
    Price, Anita P.
    Meyers, Paul A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 1029 - 1034